Zobrazeno 1 - 10 of 234 pro vyhledávání: '"C, Traversari"'
1
The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms
Autor: Porcellini S., Asperti C., Valentinis B., Tiziano E., Mangia P., Rizzardi G. P, C. Traversari, BORDIGNON , CLAUDIO
NGR-TNF is a vascular targeting agent in advanced clinical development, coupling tumor necrosis factor-a (TNF) with the CNGRCG peptide, which targets a CD13 isoform specifically expressed by angiogenic vessels. Antitumor efficacy of NGR-TNF has been
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10495::72a297a5002d88240d3f4345b5037943
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Multiple HLA-A alleles can present an immunodominant peptide of the human melanoma antigen Melan-A/MART-1 to a peptide-specific HLA-A*0201+ cytotoxic T cell line
Autor: K, Fleischhauer, S, Tanzarella, H J, Wallny, C, Bordignon, C, Traversari
The majority of HLA-A*0201-restricted tumor-infiltrating lymphocytes from melanoma patients recognize a peptide, MT(27-35), derived from the Melan-A/MART-1 Ag. This study reports that six variants of HLA-A2 and the HLA-A28 subtype A*6901 can present
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc1b50e5618f02efc936aa44de3a7b06
Zobrazit plný text záznamu
7
A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes
Autor: E S, Schultz, Y, Zhang, R, Knowles, J, Tine, C, Traversari, T, Boon, P, van der Bruggen
Publikováno v: Tissue antigens. 57(2)
Antigens encoded by MAGE genes are of particular interest for cancer immunotherapy because of their strict tumoral specificity and because they are shared by many tumors. Antigenic peptide EVDPIGHLY encoded by MAGE-3 and known to be presented by HLA-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1758f50f9bc41f78edcb1e754ee1565a
https://pubmed.ncbi.nlm.nih.gov/11260504
Zobrazit plný text záznamu
8
Identification of tumor antigen-specific cytotoxic T lymphocytes cross-recognizing allogeneic major histocompatibility class I molecules
Autor: K, Fleischhauer, L, Gattinoni, G, Lietti, E, Zino, C, Bordignon, C, Traversari
Publikováno v: Tissue antigens. 56(1)
Adoptive immunotherapy of cancer utilizes tumor antigen-specific cytotoxic T lymphocytes (CTL) as mediators of a targeted anti-tumor effect. In this study, we show that such CTL can be able to cross-recognize allogeneic major histocompatibility compl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cf7c33c2b1bea204e0c7b316a28d6352
https://pubmed.ncbi.nlm.nih.gov/10958352
Zobrazit plný text záznamu
9
Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s)
Autor: M A, Imro, S, Manici, V, Russo, G, Consogno, M, Bellone, C, Rugarli, C, Traversari, M P, Protti
Publikováno v: Cancer research. 59(10)
CTLs were generated in vitro from two healthy donors and one melanoma patient by stimulation of CD8+ T cells with autologous dendritic cells pulsed with natural melanoma peptides (NMPs), obtained by acid treatment of HLA-matched melanoma cells. CTLs
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4bff1dacfa4a256690f8ee2e42b0b31e
https://pubmed.ncbi.nlm.nih.gov/10344730
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje